Ohio Catastrophic Injury and Product Liability Lawyer Investigating Cardiovascular events
Over the past ten years, several notable mass tort pharmaceutical claims have involved allegations that widely used medications cause cardiovascular events. Recent examples include the drugs Avandia, Vioxx, and Yaz (Yasmin). Currently, there are hundreds of lawsuits pending involving Testosterone Replacement Therapy. There are allegations that the medication causes the development of cardiovascular events at higher rates than the pharmaceutical companies had previously warned.
More and more medical literature is suggesting medications aimed to improve a quality of life may put healthy patients at risk of cardiac events. The American Heart Association has released statements that warn many prescription and over-the-counter drugs can cause or worsen heart failure.
Joe Lyon is a highly-rated and experienced Cincinnati Personal Injury Lawyer who has represented numerous individuals in serious cardiac incident cases in various types of law, ranging from Pharmaceutical Liability, Medical Malpractice, and even Catastrophic Injury.
Cardiovascular events refer to any event that may cause damage to the heart. Some common events include the following:
Medical science has long identified contributing factors to cardiac events. Some are more natural, and other causes, such as damaging medications, have only recently been associated with heart issues. The most commonly known triggers are listed below:
Fluoroquinolones have been linked to higher than average rates of Aortic Dissection and other cardiac events in a varied and growing body of medical literature. Studies, by the American Medical Association and numerous medical journals, show a link between the use of fluoroquinolone antibiotics create a substantial risk for aortic aneurysms and aortic dissections. The 2015 studies identify an association between these drugs and potentially fatal cardiac injuries.
Popular fluoroquinolones include:
Based on a review in 2014, the U.S. Food and Drug Administration (FDA) concluded that there is a possible increased cardiovascular risk associated with testosterone use. Based on the findings, the FDA also required the drug manufactures to supplement the warning labels to include additional testosterone therapy side effects. Therapy with testosterone products has been suspected of contributing to a high risk of heart attacks, pulmonary embolus, deep vein thrombosis, and strokes. Specific products named include the following drugs:
• Depo Testosterone
The question of causation in toxic tort cases is always complex and requires expert testimony that is based in reliable data and facts, reliable scientific methodology, and application of the facts to the methodology. Credible medical literature and foundational case specific facts are paramount.
Under Ohio law and the law of many states, it is not necessary that the Plaintiff prove that the medication was the sole cause of the injury. In toxic tort cases, Ohio Courts have applied the ” substantial contributing factor” test on causation. In layman’s terms, risk factors do not preclude a finding of liability. As long as the medication played a substantial role in causing the cardiovascular event, in combination with the risk factors, the law supports a finding of liability against the drug company for failing to warn about the side effect.
Joe Lyon successfully represented plaintiffs in Vioxx, Yaz, and Avandia. The Lyon Firm is currently representing Plaintiffs in Testosterone Replacement Therapy and making similar arguments on the mechanism of injury between the medication and association with cardiovascular events. For questions related to cardiovascular events and medication, contact The Lyon Firm.
If you need help understanding whether a pharmaceutical product was a contributing factor in causing a cardiovascular event, or whether a delay in medical care allowed such an event to occur, call The Lyon Firm at 800.513.2403 to speak with Mr. Lyon directly.
While we cannot take every case, we strive to provide more information to each client than what they had when they called.